NSPR InspireMD Inc

USD 2.28 0.03 1.404444
Icon

InspireMD Inc (NSPR) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.28

+0.03 (+1.40)%

USD 0.05B

0.03M

USD 4.50(+97.23%)

N/A

Icon

NSPR

InspireMD Inc (USD)
COMMON STOCK | NSD
USD 2.28
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.05B

N/A

USD 2.28

InspireMD Inc (NSPR) Stock Forecast

Show ratings and price targets of :
USD 4.50
(+97.23%)

Based on the InspireMD Inc stock forecast from 1 analysts, the average analyst target price for InspireMD Inc is USD 4.50 over the next 12 months. InspireMD Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of InspireMD Inc is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, InspireMD Inc’s stock price was USD 2.28. InspireMD Inc’s stock price has changed by -1.23% over the past week, -16.42% over the past month and +100.14% over the last year.

No recent analyst target price found for InspireMD Inc
No recent average analyst rating found for InspireMD Inc

Company Overview InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid emb...Read More

https://www.inspiremd.com

4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832

65

December

USD

USA

Adjusted Closing Price for InspireMD Inc (NSPR)

Loading...

Unadjusted Closing Price for InspireMD Inc (NSPR)

Loading...

Share Trading Volume for InspireMD Inc Shares

Loading...

Compare Performance of InspireMD Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NSPR

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To InspireMD Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM
DexCom Inc -0.45 (-0.32%) USD51.34B 103.24 55.96

ETFs Containing NSPR

Symbol Name NSPR's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About InspireMD Inc (NSPR) Stock

Based on ratings from 1 analysts InspireMD Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on NSPR's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for NSPR is USD 4.50 over the next 12 months. The maximum analyst target price is USD 4.5 while the minimum anlayst target price is USD 4.5.

NSPR stock's Price/Earning ratio is 0.59. Our analysis grades NSPR stock's Price / Earning ratio at C+. This means that NSPR stock's Price/Earning ratio is above 23% of the stocks in the Medical Devices sector in the NSD exchange. Based on this NSPR may be undervalued for its sector.

The last closing price of NSPR's stock was USD 2.28.

The most recent market capitalization for NSPR is USD 0.05B.

Based on targets from 1 analysts, the average taret price for NSPR is projected at USD 4.50 over the next 12 months. This means that NSPR's stock price may go up by +97.23% over the next 12 months.

We can't find any ETFs which contains InspireMD Inc's stock.

As per our most recent records InspireMD Inc has 65 Employees.

InspireMD Inc's registered address is 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832. You can get more information about it from InspireMD Inc's website at https://www.inspiremd.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...